Cargando…

Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study

OBJECTIVES: To examine the safety of an agonist-type treatment, lisdexamfetamine (LDX), at 250 mg/day among adults with methamphetamine (MA) dependence. DESIGN: A dose-escalating, phase-2, open-label, single-group study of oral LDX at two Australian drug treatment services. SETTING: The study was co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ezard, Nadine, Clifford, Brendan, Dunlop, Adrian, Bruno, Raimondo, Carr, Andrew, Liu, Zhixin, Siefried, Krista J, Lintzeris, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Addiction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137170/ https://www.ncbi.nlm.nih.gov/pubmed/34006547 http://dx.doi.org/10.1136/bmjopen-2020-044696

Ejemplares similares

LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2018)

Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2016)

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal
por: Acheson, Liam S., et al.
Publicado: (2022)

Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
por: Siefried, Krista J., et al.
Publicado: (2020)

Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes
por: Stuart, Alexandra, et al.
Publicado: (2017)

“There’s a big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia
por: Clifford, Brendan, et al.
Publicado: (2023)

A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing
por: Tvete, Ingunn Fride, et al.
Publicado: (2013)

A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia
por: Siefried, Krista J., et al.
Publicado: (2021)

Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effects
por: Cuzen, Natalie L, et al.
Publicado: (2015)

Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials
por: Acheson, Liam S., et al.
Publicado: (2022)

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
por: Larance, Briony, et al.
Publicado: (2020)

Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019
por: Black, Emma, et al.
Publicado: (2022)

Alcohol and substance dependence in the United Arab Emirates: a scoping review protocol
por: Fouché, Ansie, et al.
Publicado: (2023)

Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
por: Belcher, Annabelle M, et al.
Publicado: (2019)

Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study
por: Scott, Gemma, et al.
Publicado: (2023)

Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
por: Jashinski, Julia, et al.
Publicado: (2022)

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
por: Andraka-Christou, Barbara, et al.
Publicado: (2023)

Cardiopulmonary and muscular effects of different doses of high-intensity physical training in substance use disorder patients: study protocol for a block allocated controlled endurance and strength training trial in an inpatient setting
por: Loe, Henrik, et al.
Publicado: (2022)

Slow release oral morphine versus methadone for the treatment of opioid use disorder
por: Klimas, Jan, et al.
Publicado: (2019)

Drivers who tested positive for cannabis in oral fluid: a longitudinal analysis of administrative data for Spain between 2011 and 2016
por: Herrera-Gómez, Francisco, et al.
Publicado: (2019)

Exercise referral for drug users aged 40 and over: results of a pilot study in the UK
por: Beynon, Caryl M, et al.
Publicado: (2013)

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
por: Lowry, Natalie, et al.
Publicado: (2022)

Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial
por: Metrebian, Nicola, et al.
Publicado: (2021)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

A pilot study of an online universal school-based intervention to prevent alcohol and cannabis use in the UK
por: Newton, Nicola C, et al.
Publicado: (2014)

Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth
por: Hadland, Scott E, et al.
Publicado: (2014)

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model
por: Laramée, Philippe, et al.
Publicado: (2014)

Two-group randomised, parallel trial of cognitive and exposure therapies for problem gambling: a research protocol
por: Smith, David P, et al.
Publicado: (2013)

A brief intervention for drug use, sexual risk behaviours and violence prevention with vulnerable women in South Africa: a randomised trial of the Women’s Health CoOp
por: Wechsberg, Wendee M, et al.
Publicado: (2013)

The persistence of adolescent binge drinking into adulthood: findings from a 15-year prospective cohort study
por: Degenhardt, Louisa, et al.
Publicado: (2013)

Mansonella ozzardi corneal lesions in the Amazon: a cross-sectional study
por: Vianna, Lucas Monferrari Monteiro, et al.
Publicado: (2012)

Paramedic-supplied ‘Take Home’ Naloxone: protocol for cluster randomised feasibility study
por: Moore, Chris, et al.
Publicado: (2014)

‘I can't be an addict. I am.’ Over-the-counter medicine abuse: a qualitative study
por: Cooper, Richard J
Publicado: (2013)

The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales
por: Marteau, Dave, et al.
Publicado: (2015)

Do parents play different roles in drinking behaviours of male and female adolescents? A longitudinal follow-up study
por: Hung, Chao-Chia, et al.
Publicado: (2015)

Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland
por: Taylor, Mark, et al.
Publicado: (2012)

Socioeconomic determinants of risk of harmful alcohol drinking among people aged 50 or over in England
por: Iparraguirre, José
Publicado: (2015)

Role of parenting styles in adolescent substance use: results from a Swedish longitudinal cohort study
por: Berge, J, et al.
Publicado: (2016)

Systematic critical review of previous economic evaluations of smoking cessation during pregnancy
por: Jones, Matthew, et al.
Publicado: (2015)

Systematic review of interventions to reduce illicit drug use in female drug-dependent street sex workers
por: Jeal, Nikki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0kjt82mnbr2km4lu3jo3vvcr2t